Cellectis acquires assets from Cyto Pulse Sciences Inc.

13-Sep-2010 - USA

Cellectis has announced that it has acquired all the assets of Cyto Pulse Sciences Inc., a US-based company specializing in the development, manufacture and commercialization of electroporation technology and equipment. The transaction value of $2.2 million was paid in cash and closed on September 2, 2010.

“Cyto Pulse’s assets are a great strategic fit for Cellectis,” said André Choulika, Chief Executive Officer of Cellectis. “As we announced last year, part of our development strategy is to acquire businesses that complement our existing meganuclease platform and that can be leveraged across all aspects of our business, from research to therapeutics. We saw such an opportunity in the technologies at Cyto Pulse Sciences Inc. and look forward to unlocking the value of these assets.”

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances